U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533032) titled 'Dose-Response Effect of Phosphatidylserine on eSport Performance' on April 09.
Brief Summary: This study will evaluate the effects of daily phosphatidylserine supplementation on electronic gaming performance, cognitive function, sleep quality, stress-related outcomes, and autonomic responses in healthy adult gamers. Participants will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group study and assigned to receive placebo, 100 mg phosphatidylserine, or 200 mg phosphatidylserine daily for 6 weeks.
Outcome measures will be assessed at baseline, Week 3, and Week 6 and will include electronic gaming performan...